Breckenridge Pharmaceutial, Inc. v. Novartis Pharmaceuticals Corporation > Summary
Court Case Number IPR2017-01592
Filing Date Jun 12, 2017
Institution Decision Date Jan 3, 2018
Decision Date Jun 3, 2019
Court Patent Trial and Appeal Board
Status Terminated-Settled
Administrative JudgesRobert A. Pollock, Sheridan K. Snedden, Jacqueline T. Harlow
Judge Writing the Final DecisionRobert A. Pollock
Claims Challenged in the Petition: 1, 2, 3, 5, 6, 7, 8, 9
Claims Instituted: 1, 2, 3, 5, 6, 7, 8, 9
Petitioner
Patent Owner
Petitioner Attorneys
8Breckenridge Pharmaceutical
Attorney Name: Jeffrey D. Blake
Merchant & Gould
Breckenridge Pharmaceutical
Attorney Name: Melissa M. Hayworth
Merchant & Gould
Breckenridge Pharmaceutical
Attorney Name: Daniel Ray Evans
Merchant & Gould
Breckenridge Pharmaceutical
Attorney Name: Keith A. Zullow
Goodwin Procter LLP
Breckenridge Pharmaceutical
Attorney Name: Marta Elizabeth Delsignore
Goodwin Procter LLP
Breckenridge Pharmaceutical
Attorney Name: Michael B. Cottler
Goodwin Procter LLP
Breckenridge Pharmaceutical
Attorney Name: Matthew Lennington Fedowitz
Merchant & Gould
Breckenridge Pharmaceutical
Attorney Name: Allan J. Pantuck
Merchant & Gould
Patent Owner Attorneys
7Novartis
Attorney Name: Nicholas N. Kallas
Venable
Novartis
Attorney Name: Laura K Fishwick
Venable
Novartis
Attorney Name: Christina A. Schwarz
Venable
Novartis
Attorney Name: Jared L. Stringham
Venable
Novartis
Attorney Name: Susanne L. Flanders
Venable
Novartis
Attorney Name: Charlotte C. Jacobsen
Venable
Novartis
Attorney Name: Howard A. Burris III
Venable
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08410131 | Cancer treatment | Apr 2, 2013 |
